Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins

01 Apr, 2021

Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins
Photo by Wayne Chan on Unsplash

– Outpace Bio raised $30m in Series A funding.
– The round was led by ARTIS Ventures and Lyell Immunopharma, and joined by Abstract Ventures, Civilization Ventures, Mubadala Capital (the asset management arm of Mubadala Investment Company), Playground Global, Sahsen Ventures, and WRF Capital.
– Total funding to date is $30m.

Biotechnology Health Care Life Science North America Pharmaceutical Software
Crunchbase icon

Content report

The following text will be sent to our editors: